Project Details
| Acronym | AML20 |
|---|---|
| Status | Finished |
| Effective start/end date | 1/03/2024 → 28/02/2025 |
Collaborative partners
- King's College London
- Cardiff University (lead)
- University of Birmingham
Funding
- CRUK Cancer Research UK: £151,774.83
Optimising therapy for patients with FLT3 - mutated Acute Myeloid Leukaemia
- Dillon, Richard (Primary Investigator)
Project: Research